In this webinar, Dr. Mark Argentine, Senior Research Advisor at Eli Lilly and Company, describes risk-based approaches to developing and managing impurity identification and quantitation methods within the context of AQbD and MLCM and more.
Your search for developing%20impurities produced 0 results
0 results
developing%20impurities
Currently loaded videos are 0 through 0 of 0 total videos.